Tiglutik Suspension
Product Images NDC 11797-210

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Tiglutik (NDC 11797-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Italfarmaco Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (300 mL Bottle Carton)

Tiglutik riluzole oral suspension 50 mg/10 mL (5 mg/mL) packaging label from Italfarmaco SPA. The label indicates the product is for oral administration, comes as a liquid suspension supplied with syringes, and contains two bottles of 300 mL each, totaling 600 mL. The label includes usage instructions, storage information, and packaging contents. NDC 11797-210-01 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.